Prognostic interest of bone turnover markers in the management of postmenopausal osteoporosis

Joint Bone Spine

Volumn 79, Issue 1, 2012, Pages 26-31

  Chopin, Florence ^a   Biver, Emmanuel ^b   Funck Brentano, Thomas ^c   Bouvard, Béatrice ^d   Coiffier, Guillaume ^e   Garnero, Patrick ^f   Thomas, Thierry ^a  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b UNIV LILLE   (France)

^c Institut Cochin   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

^e RENNES UNIVERSITY HOSPITAL   (France)

^f INSERM   (France)

Author keywords

Bone loss; Bone turnover marker; Fracture risk; Postmenopausal osteoporosis

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL TELOPEPTIDE; BIOLOGICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; DEOXYPYRIDOLINE; OSTEOCALCIN; PYRIDOLINE; TARTRATE RESISTANT ACID PHOSPHATASE 5B; UNCLASSIFIED DRUG;

BONE DENSITY; BONE TURNOVER; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; MEASUREMENT; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; PROGNOSIS; RISK ASSESSMENT; SHORT SURVEY; SYSTEMATIC REVIEW;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BONE RESORPTION; COLLAGEN TYPE I; FEMALE; HUMANS; MALE; MEDLINE; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPOROTIC FRACTURES; PEPTIDES; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS;

EID: 84855692063     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2011.05.004     Document Type: Short Survey

References (41)

1. Consensus development conference: diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 1993, 94:646-650.
2. Kanis J.A, Melton 3rd L.J., Christiansen C., et al. The diagnosis of osteoporosis. J Bone Miner Res 1994, 9:1137-1141.
3. Garnero P. Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring. Mol Diagn Ther 2008, 12:157-170. [Review].
4. Rosenquist C., Fledelius C., Christgau S., et al. Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen. Clin Chem 1998, 44:2281-2289.
5. Garnero P., Borel O., Delmas P.D. Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis. Clin Chem 2001, 47:694-702.
6. Qvist P., Christgau S., Pedersen B., et al. Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting. Bone 2002, 31:57-61.
7. Garnero P., Sornay-Rendu E., Chapuy M.C., et al. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 1996, 11:337-349.
8. Bauer D.C., Sklarin P.M., Stone K.L., et al. Biochemical markers of bone turnover and prediction of hipbone loss in older women: the study of osteoporotic fractures. J Bone Miner Res 1999, 14:1404-1410.
9. Garnero P., Sornay-Rendu E., Duboeuf F., et al. Markers of bone turnover predict postmenopausal forearm bone loss over four years: the OFELY study. J Bone Miner Res 1999, 14:1614-1621.
10. Rogers A., Hannon R.A., Eastell R. Biochemical markers as predictors of rates of bone loss after menopause. J Bone Miner Res 2000, 15:1398-1404.
11. Finigan J, Glüer C, Felsenberg D, et al. Relationship between baseline bone turnover, subsequent vertebral fracture and bone loss. R35th European symposium on calcified tissue 2008 [abstract].
12. Ross P.D., Knowlton W. Rapid bone loss is associated with increased levels of biochemical markers. J Bone Miner Res 1998, 13:297-302.
13. Ivaska K.K., Lenora J., Gerdhem P., et al. Serial assessment of serum bone metabolism markers identifies women with the highest rate of bone loss and osteoporosis risk. J Clin Endocrinol Metab 2008, 93:2622-2632.
14. Pouillès J.M., Trémollières F., Ribot C. Vertebral bone loss in perimenopause. Results of a seven-year longitudinal study. Presse Med 1996, 25:277-280.
15. Pouillès J.M., Trémollieres F.A., Ribot C. Osteoporosis in otherwise healthy perimenopausal and early postmenopausal women: physical and biochemical characteristics. Osteoporos Int 2006, 17:193-200.
16. Rosenbrock H., Seifert-Klauss V., Kaspar S., et al. Changes of biochemical bone markers during the menopausal transition. Clin Chem Lab Med 2002, 40:143-151.
17. Akesson K., Ljunghall S., Jonsson B., et al. Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: a retrospective and prospective population-based study of women. J Bone Miner Res 1995, 10:1823-1829.
18. Melton L.J., 3rd, Khosla S., Atkinson E.J., et al. Relationship of bone turnover to bone density and fractures. J Bone Miner Res 1997, 12:1083-1091.
19. Van Daele P.L., Seibel M.J., Burger H., et al. Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study. BMJ 1996, 24:482-483.
20. Ross P.D., Kress B.C., Parson R.E., et al. Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study. Osteoporos Int 2000, 11:76-82.
21. Garnero P., Hausherr E., Chapuy M.C., et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. J Bone Miner Res 1996, 11:1531-1538.
22. Garnero P., Sornay-Rendu E., Claustrat B., et al. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res 2000, 15:1526-1536.
23. Garnero P., Cloos P., Sornay-Rendu E., et al. Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study. J Bone Miner Res 2002, 17:826-833.
24. Cosman F., Nieves J., Wilkinson C., et al. Bone density change and biochemical indices of skeletal turnover. Calcif Tissue Int 1996, 58:236-243.
25. Glover S.J., Garnero P., Naylor K., et al. Establishing a reference range for bone turnover markers in young, healthy women. Bone 2008, 42:623-630.
26. Gerdhem P., Ivaska K.K., Alatalo S.L., et al. Biochemical markers of bone metabolism and prediction of fracture in elderly women. J Bone Miner Res 2004, 19:386-393.
27. Sornay-Rendu E., Munoz F., Garnero P., et al. Identification of osteopenic women at high risk of fracture: the OFELY study. J Bone Miner Res 2005, 20:1813-1819.
28. Melton L.J., 3rd, Crowson C.S., O'Fallon W.M., et al. Relative contributions of bone density, bone turnover, and clinical risk factors to long-term fracture prediction. J Bone Miner Res 2003, 18:312-318.
29. Hellman J., Käkönen S.M., Matikainen M.T., et al. Epitope mapping of nine monoclonal antibodies against osteocalcin: combinations into two-site assays affect both assay specificity and sample stability. J Bone Miner Res 1996, 11:1165-1175.
30. Luukinen H., Käkönen S.M., Pettersson K., et al. Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. J Bone Miner Res 2000, 15:2473-2478.
31. Delmas P.D., Eastell R., Garnero P., et al. The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation. Osteoporos Int 2000, 11:S2-17.
32. Akesson K., Käkönen S.M., Josefsson P.O., et al. Fracture-induced changes in bone turnover: a potential confounder in the use of biochemical markers in osteoporosis. J Bone Miner Metab 2005, 23:30-35.
33. Ivaska K.K., Gerdhem P., Akesson K., et al. Effect of fracture on bone turnover markers: a longitudinal study comparing marker levels before and after injury in 113 elderly women. J Bone Miner Res 2007, 22:1155-1164.
34. Ingle B.M., Hay S.M., Bottjer H.M., et al. Changes in bone mass and bone turnover following ankle fracture. Osteoporos Int 1999, 10:408-415.
35. Veitch S.W., Findlay S.C., Hamer A.J., et al. Changes in bone mass and bone turnover following tibial shaft fracture. Osteopros Int 2006, 17:364-372.
36. Ingle B.M., Hay S.M., Bottjer H.M., et al. Changes in bone mass and bone turnover following distal forearm fracture. Osteoporos Int 1999, 10:399-407.
37. Blumsohn A., Naylor K.E., Timm W., et al. Absence of marked seasonal change in bone turnover: a longitudinal and multicenter cross-sectional study. J Bone Miner Res 2003, 18:1274-1281.
38. De Papp A.E., Bone H.G., Caulfield M.P., et al. A cross-sectional study of bone turnover markers in healthy premenopausal women. Bone 2007, 40:1222-1230.
39. Claudon A., Vergnaud P., Valverde C., et al. New automated multiplex assay for bone turnover markers in osteoporosis. Clin Chem 2008, 54:1554-1563.
40. Adami S., Bianchi G., Brandi M.L., et al. Bonturno Study Group Determinants of bone turnover markers in healthy premenopausal women. Calcif Tissue Int 2008, 82:341-347.
41. Glover S.J., Gall M., Schoenborn-Kellenberger O., et al. Establishing a reference interval for bone turnover markers in 637 healthy, young, premenopausal women from the United Kingdom, France, Belgium, and the United States. J Bone Miner Res 2009, 24:389-397.